Cargando…

P413: GENOMIC AND TRANSCRIPTOMIC ANALYSES OF NORMAL KARYOTYPE PRIMARY REFRACTORY ACUTE MYELOID LEUKAEMIA REVEAL HIGH INCIDENCE OF WT1 MUTATIONS AND A TRANSCRIPTIONAL SIGNATURE OF SENESCENCE.

Detalles Bibliográficos
Autores principales:	Alhawaj, Ali, Conde, Lucia, D Kottaridis, Panagiotis, E Gale, Rosemary, L Linch, David, Mansour, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428862/ http://dx.doi.org/10.1097/01.HS9.0000968560.57167.d3

Ejemplares similares

Wilms’ Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses
por: Uttenthal, Benjamin, et al.
Publicado: (2014)

The value of molecular stratification for CEBPA (DM) and NPM1 (MUT) FLT3 (WT) genotypes in older patients with acute myeloid leukaemia
por: Dickson, Glenda J., et al.
Publicado: (2015)

Distinctive Patterns of MicroRNA Expression Associated with Karyotype in Acute Myeloid Leukaemia
por: Dixon-McIver, Amanda, et al.
Publicado: (2008)

PB1901: KARYOTYPIC PROFILE OF CHRONIC MYELOID LEUKAEMIA DIAGNOSED AT TERTIARY LEVEL IN AFGHANISTAN.
por: Haidary, A. M., et al.
Publicado: (2022)

Detailed molecular characterisation of acute myeloid leukaemia with a normal karyotype using targeted DNA capture
por: Conte, N, et al.
Publicado: (2013)

Schedule of experiment R413
por: Jarlskog, G
Publicado: (1973)

Progress report of R413
por: CERN. Geneva. Intersecting Storage-Rings Committee
Publicado: (1974)

Genomic Imbalances Are Confined to Non-Proliferating Cells in Paediatric Patients with Acute Myeloid Leukaemia and a Normal or Incomplete Karyotype
por: Ballabio, Erica, et al.
Publicado: (2011)

Prospects for achieving treatment‐free remission in chronic myeloid leukaemia
por: Saglio, Giuseppe, et al.
Publicado: (2020)

Significance of nucleophosmin1 (NPM1) gene mutation status on acute myeloid leukaemia patients with normal karyotype in South India
por: Sureshkumar, R, et al.
Publicado: (2014)

Somatic mutations of isocitrate dehydrogenases 1 and 2 are prognostic and follow-up markers in patients with acute myeloid leukaemia with normal karyotype
por: Virijevic, Marijana, et al.
Publicado: (2016)

Molecular techniques for the personalised management of patients with chronic myeloid leukaemia
por: Alikian, Mary, et al.
Publicado: (2017)

Scheduling of R410/R413 in 1975
por: CERN. Geneva. Intersecting Storage-Rings Committee
Publicado: (1974)

Genomic Alterations, Gene Expression Profiles and Functional Enrichment of Normal-Karyotype Acute Myeloid Leukaemia Based on Targeted Next-Generation Sequencing
por: Ambayya, Angeli, et al.
Publicado: (2023)

Intensive Chemotherapy Is Associated With Poor Overall Survival in Autoimmune Disease-associated Myeloid Malignancies
por: Richardson, Simon E., et al.
Publicado: (2018)

Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia
por: Tse, Eric, et al.
Publicado: (2011)

Chemotherapy of the Myeloid Leukaemias
por: Stuart, John
Publicado: (1980)

COVID-19 in persons with chronic myeloid leukaemia
por: Li, Weiming, et al.
Publicado: (2020)

Development and validation of a 10‐gene prognostic signature for acute myeloid leukaemia
por: Yang, Zuyi, et al.
Publicado: (2020)

Transcriptional signatures of the BCL2 family for individualized acute myeloid leukaemia treatment
por: Lee, Chansub, et al.
Publicado: (2022)

A Nucleus-Targeting WT1 Antagonistic Peptide Encapsulated in Polymeric Nanomicelles Combats Refractory Chronic Myeloid Leukemia
por: Chen, Mengting, et al.
Publicado: (2023)

Karyotype complexity and prognosis in acute myeloid leukemia
por: Stölzel, F, et al.
Publicado: (2016)

An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype
por: Chuang, Ming-Kai, et al.
Publicado: (2015)

Views from the experiments R410 and R413
por: CERN PhotoLab
Publicado: (1975)

Views from the experiments R410 and R413
por: CERN PhotoLab
Publicado: (1975)

41.3 COULD CLOZAPINE REDUCE VIOLENT OFFENDING?
por: Bhavsar, Vishal, et al.
Publicado: (2018)

Human circulating small non-coding RNA signature as a non-invasive biomarker in clinical diagnosis of acute myeloid leukaemia
por: Xia, Lin, et al.
Publicado: (2023)

Venetoclax combination therapy with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukaemia
por: Báez-Gutiérrez, Nerea, et al.
Publicado: (2021)

Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
por: Ladikou, E. E., et al.
Publicado: (2020)

Normal myeloid progenitor cell subset-associated gene signatures for acute myeloid leukaemia subtyping with prognostic impact
por: Schönherz, Anna A., et al.
Publicado: (2020)

Wt-p53 action in human leukaemia cell lines corresponding to different stages of differentiation.
por: Rizzo, M. G., et al.
Publicado: (1998)

Erythropoiesis in Murine Myeloid Leukaemia
por: Tanaka, T.
Publicado: (1970)

Desacetylmethylcolchicine in the Treatment of Myeloid Leukaemia
por: Jelliffe, A. M., et al.
Publicado: (1956)

A Case of Myeloid Leukæmia
por: Ghosal, J. N.
Publicado: (1931)

Asciminib for chronic myeloid leukaemia
Publicado: (2022)

A 4‐gene expression score associated with high levels of Wilms Tumor‐1 (WT1) expression is an adverse prognostic factor in acute myeloid leukaemia
por: Niavarani, Ahmadreza, et al.
Publicado: (2016)

Monosomal karyotype in myeloid neoplasias: a literature review
por: Anelli, Luisa, et al.
Publicado: (2017)

Exam 70-413 : designing and implementing an enterprise server infrastructure
por: Ferrill, Paul, et al.
Publicado: (2014)

Request for permission to install R413 in the Christmas shutdown 1974
por: CERN. Geneva. Intersecting Storage-Rings Committee
Publicado: (1974)

413 Effect of Hydrolysis and Polymerization on Bovine Beta-lactoglobulin Immunoreactivity
por: Villas-Boas, Mariana Battaglin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2mp5k308itd8i5ceqmrpkpk12s